Showing results (521-530 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|December 10, 2022
A Study to Evaluate Relative Bioavailability, Food Effect, and Pharmacodynamics of Tropifexor, a Farnesoid X Receptor Agonist, in Healthy ParticipantsRowan Stringer, Jin Chen, Bharti Shah, et al.
Clinical Pharmacology in Drug Development|January 18, 2021
Phase 1 Concentration-QTc and Cardiac Safety Analysis of the MDM2 Antagonist KRT-232 in Patients With Advanced Solid Tumors, Multiple Myeloma, or Acute Myeloid LeukemiaAdekemi Taylor, Dana Lee, Martine Allard, et al.
Clinical Pharmacology in Drug Development|January 19, 2021
Safety, Tolerability, and Pharmacokinetics of Multiple Repeated Oral Doses of the α2/3/5-Subtype Selective GABAA -Positive Allosteric Modulator PF-06372865 in Healthy VolunteersRachel Gurrell, Mark Whitlock, Hua Wei, et al.
Clinical Pharmacology in Drug Development|September 26, 2019
Clinical Evaluation of the Tolerability and Pharmacokinetics of Azilsartan, a Potent Angiotensin Receptor Blocker, in Healthy Chinese SubjectsXiaojiao Li, Jingrui Liu, Changcheng Sheng, et al.
Clinical Pharmacology in Drug Development|January 17, 2021
Evaluation of the CYP3A and CYP2B6 Drug-Drug Interaction Potential of LemborexantIshani Landry, Jagadeesh Aluri, Kenya Nakai, et al.
Clinical Pharmacology in Drug Development|January 25, 2021
Safety, Pharmacokinetics, and Neutralizing Activity of SYN023, a Mixture of Two Novel Antirabies Monoclonal Antibodies Intended for Use in Postrabies Exposure ProphylaxisJ Bruce McClain, Ariel Chuang, Susan M Moore, et al.
Clinical Pharmacology in Drug Development|February 20, 2019
Pharmacokinetics, Food Effect, Ketoconazole Interaction, and Safety of JTK-853, a Novel Nonnucleoside HCV Polymerase Inhibitor, After Ascending Single and Multiple Doses in Healthy SubjectsSekihiro Tamaki, Tsutomu Shibata, Thomas Hunt, et al.
Clinical Pharmacology in Drug Development|February 21, 2019
A Phase 3, Randomized, Placebo-Controlled Evaluation of the Safety of Intravenous Meloxicam Following Major SurgerySergio D Bergese, Timothy I Melson, Keith A Candiotti, et al.
Clinical Pharmacology in Drug Development|November 22, 2016
Ascending Single-Dose, Double-Blind, Placebo-Controlled Safety Study of Noribogaine in Opioid-Dependent PatientsPaul Glue, Gavin Cape, Donna Tunnicliff, et al.
Clinical Pharmacology in Drug Development|March 17, 2017
Effects of Tenapanor on Cytochrome P450-Mediated Drug-Drug InteractionsSusanne Johansson, David P Rosenbaum, Marie Ahlqvist, et al.
Pageof 136